FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

24 Sep 14

Cancer Genetics Inc. to Provide Updates About the Company's Portfolio of Targeted Molecular Diagnostics at Analyst Day on September 25, 2014 (read more...)

- RUTHERFORD, N.J. and RALEIGH, N.C., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging (read more...)
23 Sep 14

Cancer Genetics, Inc. and Beth Israel Deaconess Medical Center Enter Into Collaboration to Correlate Genomic Profiles to Patient Outcome in Diffuse Large B-Cell Lymphoma (read more...)

- Study will correlate genetic markers to outcome in ~200 patients with diffuse large B-cell lymphoma (DLBCL), the most common form of non-Hodgkin(read more...)

Events

06 Dec 14

ASH Annual Meeting

14 Nov 14

Iowa Oncology Society Fall Membership Conference

13 Nov 14

2014 Iowa Association of Pathologists Annual Dinner

Clinicians
Patients